A) The ease of obtaining stem cells from adults. B) The lack of potential applications. C) The uncontroversial ethical implications. D) The use of embryonic stem cells.
A) Speed of research progress above all else. B) Ethical guidelines and regulations. C) Ignoring public opinions and concerns. D) Funding from private corporations only.
A) To address regulatory disparities and ensure ethical standards. B) To avoid sharing scientific breakthroughs. C) To eliminate competition among research institutions. D) To hinder progress in the field.
A) Opposing all forms of medical research involving stem cells. B) Serving as decision-makers for all stem cell research projects. C) Providing expertise on ethical implications and considerations. D) Advocating for unrestricted research with no ethical oversight.
A) Developing international policy guidance on stem cell research. B) Excluding patient advocates from the research process. C) Promoting unregulated stem cell experimentation. D) Creating financial barriers to stem cell research.
A) Pluripotent cells are more versatile than totipotent cells. B) Pluripotent cells can only divide a limited number of times. C) There is no difference between the two types of stem cells. D) Totipotent cells can develop into any type of cell, including embryonic tissues, while pluripotent cells can develop into almost any type of cell.
A) Speed up the aging process in patients. B) Create artificial intelligence using stem cells. C) Repair, replace, and regenerate damaged cells or tissues. D) Replace traditional medicine for all illnesses.
A) To only focus on economic factors. B) To prioritize scientific progress over societal implications. C) To address diverse views on ethics, religious beliefs, and values that impact policy decisions. D) To ignore public opinions and concerns. |